Zobrazeno 1 - 10
of 101
pro vyhledávání: '"Elizabeth Lee Lewandrowski"'
Publikováno v:
American Journal of Clinical Pathology.
ObjectivesTwo-tiered serologic testing for Lyme disease is usually performed using an enzyme-linked immunosorbent assay (ELISA) as the first-tier test. The Quidel Sofia 2 Lyme test is a relatively new lateral flow method to provide more rapid turnaro
Autor:
Kent B. Lewandrowski, Kimberly Gregory, Jeannette Le, Lee Goldstein, Elizabeth-Lee Lewandrowski
Publikováno v:
Clinica Chimica Acta. 522:127-131
Background Point-of-care testing (POCT) is an important component of hospital-based and ambulatory laboratory testing. Despite its importance, there is relatively little in the peer reviewed literature describing the details of successful POCT progra
Publikováno v:
Annals of clinical and laboratory science. 52(2)
In patients with early Lyme disease (ELD), cardiac involvement is known to occur in approximately 1% of patients. We measured high-sensitivity troponin T (hsTnT) in patients with early Lyme disease to evaluate the possibility of subclinical cardiac i
Publikováno v:
American Journal of Clinical Pathology. 150:415-420
Objectives We evaluated changes in the testing menu, volume, and positivity rates for tick-borne illnesses in a New England medical center over an 11-year time frame. Methods Testing data were obtained by a retrospective review utilizing searchable d
Autor:
Elizabeth Lee-Lewandrowski, Liyang Yu, D. Dante Yeh, Yuchiao Chang, Kent B. Lewandrowski, Colleen Arsenault, Nalin Chokengarmwong, Joseph W Rudolf
Publikováno v:
Journal of Critical Care. 42:147-151
Purpose Ionized fraction (iMg) is the physiologically active form of magnesium (Mg); total Mg may not accurately reflect iMg status. Erroneously “low” Mg levels may result in unnecessary repetitive testing. Materials and methods From 11/2015 to 0
Autor:
Jason M. Baron, Elizabeth-Lee Lewandrowski, Sunu Yeh, J. Benjamin Crocker, Kent B. Lewandrowski
Publikováno v:
Clinica Chimica Acta. 473:71-74
In a previous study we reported on the impact of point-of-care testing (POCT) on practice efficiency in an academic primary care practice that was established to develop new models of care delivery. Here we report a follow-on confirmation study in a
Publikováno v:
American journal of clinical pathology. 153(1)
ObjectivesWe evaluated trends in non-Lyme disease tick-borne disease (NLTBI) testing at a national reference laboratory.MethodsTesting data performed at Quest Diagnostics during 2010 to 2016 were analyzed nationally and at the state level.ResultsTest
Publikováno v:
American journal of clinical pathology. 152(1)
Objectives We evaluated trends in Lyme disease (LD) testing at a national reference laboratory. Methods LD screening enzyme immunoassay and Western blot testing data performed at Quest Diagnostics during 2010 to 2016 were analyzed nationally and at t
Can a Point-of-Care Troponin I Assay be as Good as a Central Laboratory Assay? A MIDAS Investigation
Autor:
William Arnold, John T. Nagurney, Chadwick D. Miller, Elizabeth Lee-Lewandrowski, Jon W. Schrock, Robert H. Birkhahn, Judd E. Hollander, Francis L. Counselman, Deborah B. Diercks, Abhinav Chandra, Basmah Safdar, Joshua M. Kosowsky, Mary Ann Peberdy, Richard Nowak, Adam J. Singer, W. Frank Peacock, James Neuenschwander
Publikováno v:
Annals of Laboratory Medicine
Background We aimed to compare the diagnostic accuracy of the Alere Triage Cardio3 Tropinin I (TnI) assay (Alere, Inc., USA) and the PathFast cTnI-II (Mitsubishi Chemical Medience Corporation, Japan) against the central laboratory assay Singulex Eren
Publikováno v:
American journal of clinical pathology. 150(5)
We evaluated changes in the testing menu, volume, and positivity rates for tick-borne illnesses in a New England medical center over an 11-year time frame.Testing data were obtained by a retrospective review utilizing searchable data from a laborator